Fueling Positive Patient Outcomes and Revenue Growth

    Rubicon equips C-Suite, Marketing VP's, and R&D leaders with KOL-validated market intelligence, rigorous segmentation, and board-ready financial models through fractional and traditional consulting.

    • ✓ 100+ KOL Engagements Across Specialties
    • ✓ $2M+ Protected From Non-Viable Investment
    • ✓ 20+ Markets Evaluated for Commercial Potential

    Convert Clinical Insight into Market Traction

    100+

    Engaged 100+ KOLs across specialties to validate needs and specifications across numerous product classes

    $2M+

    Helped companies avoid at least $2 million in non-viable investment

    20+

    Evaluated over 20 markets to focus spend where the highest revenue is attainable

    Rob Miraglia: Your Partner in MedTech Growth.

    Rob turns clinical promise into commercial growth. With over 25 years of leadership and management at Abbott, Medtronic, Integer, and 3M, he helps teams validate high-stakes investments, develop products, and turn medical innovation into market growth.

    With expertise spanning 20+ markets and 100+ KOL engagements, Rob specializes in identifying high-growth opportunities. His strategic guidance ensures funding goes to the right ideas for commercial growth and risk mitigation.

    Rob Miraglia

    The Track Record Behind Rubicon: What Industry Leaders Say About Working With Rob

    200+ Sales Reps Trained. 5,000 Clinics Targeted. Goals Exceeded in Year One.

    Equipping innovators in MedTech and Life Science to win the launch, accelerate adoption, and sustain advantage. Rob oversaw the launch of a strategic product for our company...

    Barry R. Hix

    MBA, MPH

    Built a Best-in-Class Clinical Stakeholder Network That Drove Business Opportunities

    Rob played a key role in advancing market initiatives in his position as Senior Product Marketing Manager at Lake Region Medical. While reporting to me, Rob completed a...

    Toby Ahlbrecht

    Director of Product Management at Integer Holdings Corporation

    A Natural at Drawing Out the Voice of Customer Intelligence That Drives New Product Development

    Rob is a strong contributor with deep insights which have helped us greatly. In working closely with him, I have witnessed how well he is able to draw valuable voice of customer...

    Rick Kirchner

    R&D Executive

    The IDEA Process

    Our four-stage framework ensures strategic consensus, landscape transparency, and data-driven discovery to provide board-ready outcomes grounded in market reality.

    Immersion and inquiry

    (Initial Meeting)

    Project Objective(s)

    • •Meet with the executive sponsor to align on goals, constraints, and how success will be measured.
    • •Understand the landscape: therapeutic area, competitive set, and current market dynamics
    • •Map internal and external stakeholders, including KOLs, clinical users, and commercial teams
    • •Learn pain points, unanswered questions, and where your team feels least certain today
    • •Clarify likely travel and touchpoints (conferences, KOL visits, client offices)
    • •Capture initial thoughts on strategy and expected deliverables to test later against the data

    Deliverable: Every engagement begins with a deep-dive into your real-world environment and project constraints, and to guide the IDEA process, we deliver a Statement of Understanding and a Statement of Work, a clear-eyed blueprint that transforms high-level goals into a validated, executable plan for your project.

    Delineate project roadmap

    (Define Plan and Strategy)

    Build project roadmap and plan

    • •Translate business questions into a focused learning plan and research strategy
    • •Plan for qualitative, quantitative, environmental, and or competitive research and analysis
    • •Define where we will learn: conferences, KOL IDIs, internal teams, and other key settings
    • •Align on when: timing of milestones and deliverables that match your internal decision calendar
    • •Outline how we will execute to minimize disruption to busy clinical and commercial stakeholders

    Deliverable: A reviewed and finalized plan with the executive sponsor and your core team that spells out what we need to know and how we will learn it.

    Engage full team for plan execution

    (Team Kickoff)

    Run the work, talk to the right people, and turn raw data into usable insight

    • •Validate project roadmap with larger team, obtain feedback, and conduct gap analysis
    • •Leverage data analytics to codify market segmentation, competitive landscape, growth, and growth drivers
    • •Synthesize clinical intelligence by distilling procedural nuances and comparative evidence to inform discussion guides, surveys, and other research instruments
    • •Develop discussion guides (with scoring when appropriate) and orchestrate expert in-depth interviews (IDIs) to extract deep domain insights for product development
    • •Validate qualitative research by deploying quantitative research methods on a larger sample to mitigate risk
    • •Collaborate with larger team for product development, finance, and marketing alignment
    Action and advise

    (Next Steps)

    Execute on plan, report, and advise

    • •Translate research into clear product requirements in collaboration with the executive sponsor
    • •Work with R&D and other stakeholders to suggest high-level or detailed product specifications
    • •Identify any additional market research or advisory board needs to de-risk remaining questions
    • •Outline recommended targeting and positioning strategies based on the evidence gathered
    • •Draft initial concepts for messaging and work with downstream marketing if desired

    Marketing and creative deliverables may include:

    • •Briefs for the creative team that inform campaigns and market development programs
    • •Draft or refine the value proposition, tagline, and elevator pitch
    • •Create messaging architecture and a simple user experience template by segment

    Business and investment deliverables may include:

    • •Business briefs for the investment team
    • •An investment case, go-to-market strategy, and market or patient models that support board and leadership decisions

    Roadmap Briefing and Report:

    • •Executive Summary
    • •Competitive Landscape
    • •Draft product specifications and product SWOT analysis
    • •Forecasted Market Shares, Revenue, Units, ASPs, Margin, and Growth
    • •Risk mitigation planning with additional market research, advisory board development, etc
    • •Suggested Targeting, Positioning, Value Proposition, Positioning Statement, Messaging, and Go-to-Market strategies
    • •Next Steps and Questions

    Deliverable: A full concept report and presentation that links every recommendation back to the evidence gathered in the IDEA process.

    Six Ways Rubicon Turns Clinical and Market Intelligence Into Defensible Commercial Decisions

    Precision Before Investment: The Rubicon Model

    Precision before investment. We use VoC and predictive modeling to quantify market demand and identify barriers, allowing you to cut low-ROI projects and invest in only winners.

    Precision Before Investment: The Rubicon Model

    In the high-stakes environment of MedTech development, the most expensive mistake companies make is funding a product that the market doesn't want, the clinical data don't support, or the geometries and construction are insufficient. We serve as the strategic "gate" between an idea and a multi-million dollar investment

    Enter the Market With a Defensible Competitive Advantage

    We convert KOL insights into the market segments and clinical claims your sales team needs to win — before your competitors find them first.

    Enter the Market With a Defensible Competitive Advantage

    We identify your highest-value segments, translate clinical evidence into targeted positioning, and develop messaging that drives adoption and stands up to scrutiny.

    Build a Roadmap That Reflects Actual Market Demands

    Turn Clinical Evidence Into the Co-Development Partnerships That Fund Your Next Product.

    Build a Roadmap That Reflects Actual Market Demands

    Many product roadmaps are built on assumptions, not market reality. Rubicon applies Voice of Customer analysis to ensure every development decision is grounded in what clinicians, patients, and payers will support.

    $5M

    NRE Funding

    $30M

    Co-dev Investment

    How One MedTech Team Unlocked $35M in Co-Development Funding

    When clinical evidence alone isn't enough to move an executive team, you need market validation, KOL strategy, and financial modeling that makes the decision obvious. Here's exactly how that process worked — and what it produced.

    Turning Product Strategy Into Tangible Success

    $2M

    Prevented in wasted product investment

    $30M

    Forecasted revenue from new device launch

    24%

    Increase in market adoption by highest unit/clinical segment

    40+

    Projects delivered across MedTech

    Questions Leaders Ask Rubicon Before Engaging

    At what stage should we engage Rubicon?

    Earlier the better. The team has worked with companies at the product ideation stage, using KOL research, market sizing, and competitive analysis to validate the concept before commitments are made. The team has also been brought in during active launch planning when strategy needed sharper validation before go-to-market. If a market decision is on the table, the conversation is worth having.

    What does your experience with launch planning actually look like?

    Although many of Rubicon's 40+ high-stakes projects, across vascular intervention, pharmaceuticals, and diagnostics, is in the critical "Front End of Innovation," we have also provided value by applying a comprehensive launch framework, which includes the GTM strategy with playbooks, sales and other internal stakeholder training, PR and advertising, competitive dossiers, etc.

    Do you offer fractional engagements or only project-based work?

    For companies needing an embedded senior resource, Rubicon operates as a fractional partner — inside your team, driving decisions, without the full-time cost. For defined needs, Rubicon delivers project-based engagements: market assessments, KOL programs, launch planning, due diligence, etc. Timelines flex from weeks to ongoing. The first conversation determines which model serves you best.

    What does an engagement with Rubicon actually look like, start to finish?

    Every engagement begins with a deep-dive into your real-world environment and project constraints. To guide the IDEA process, Rubicon delivers a Statement of Understanding and a Statement of Work—a clear-eyed blueprint that transforms high-level goals into a validated, executable plan for your device. At the end, you will have a final presentation and full concept report and presentation that links every recommendation back to the evidence gathered in the IDEA process.

    How do we know this investment will generate a return?

    Our work has helped companies avoid $2M+ in wasted spend and helped bring >$30M in new product revenue. While innovation inherently carries uncertainty, our risk-mitigation frameworks provide the clinical and commercial confidence necessary for a successful launch.

    Every Major Market Decision Is a Rubicon Moment

    When Caesar crossed the Rubicon, there was no turning back. Your next market entry, acquisition, or product launch carries the same weight — capital at risk, timelines compressed, and the costs of a wrong move compounding fast. Rubicon ensures you cross with confidence, not assumption.